1Y Annualised Return
▲139.92%
3Y Annualised Return
▲90.89%
5Y Annualised Return
▲75.04%
10Y Annualised Return
▲17.17%
Bacil Pharma Stock Performance
|
|
|
Bacil Pharma Company background
Founded in: 1987
Incorporated as a private limited company in Maharashtra in May 87, Bacil Pharma (BPL) was converted into a public limited company in Oct.90. The main business activity of the Company is Pharmaceutical.Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic OTC products, Intravenous Infusions and Bulk Drugs. Domestic operations are spread across pan India. The company has strong field force of 500 plus, spread over various States and Districts. It has a strong distribution set up, with Super Stockist in all the States and stockists for retail coverage. To augment the domestic market, Companys operations are based on focused approach.MultiSpeciality division Vibrant specialises in various specialties, like AntiInfectives, Pain Management, Respiratory Care, Womens Health, to name a few. Aziwin, Ebay, Balvibe, MNF, Ocium and Monogesic Plus Gel (Innovative Pain Relieving Gel, first time in India) are some of the leading brands in the respective segments. Bal Vedics Division integrates modern medicine with herbal/ayurvedic preparation targeting specific conditions like, Prostrate Enlargement, Renal Calculi, Male Infertility, Women Health etc. Bal Pharma Institutional division is associated with the top Government bodies and Hospitals to extend its product range to the masses. Every area is well covered and supplied through there channel partners.Bal Pharma Unit 1, is a finished dosage facility for manufacturing Tablets and Capsules. Bal Pharma Unit 2, is involved in the manufacturing of APIs. A wellequipped RD laboratory, a good Kilo laboratory and quality control facilities form the other spheres of activity here. Bal Pharma Unit 3, is a finished dosage facility for manufacturing Intravenous Fluids, Ophthalmic Preparations Liquid Oral Preparations. BPL came out with a public issue of Rs 7 cr in Mar.94 to set up a plant at Vapi to manufacture bulk drugs like atenalol, norfloxacin, pefloxacin and ciprofloxacin. The company entered into a marketing arrangement with a distributor Kam Han Industries, Hong Kong, to export 50% of the production. Due to various reasons, the civil works at Vapi were affected. However, to avoid further delay in project implementation, the company acquired from SICOM an existing bulk drug unit with necessary infrastructure and production facilities at Lote Parashuram (near Ratnagiri).
As of 18 Aug, 2025, Bacil Pharma share price is ₹37.5. The stock opened at ₹35.6 and had closed at ₹37.5 the previous day. During today’s trading session, Bacil Pharma share price moved between ₹35.63 and ₹37.50, with an average price for the day of ₹36.56. Over the last 52 weeks, the stock has recorded a low of ₹14.85 and a high of ₹62.56. In terms of performance, Bacil Pharma share price has declined by 15.7% over the past six months and has increased by 139.92% over the last year.
Bacil Pharma SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹1,41,83,338 (+118.21%)
Daily SIP of ₹25,000 would have become ₹1,41,83,338 in 1 year with a gain of ₹76,83,338 (+118.21%)
Bacil Pharma Fundamental
Market Cap (in crs)
53.82
Face Value
10
Turnover (in lacs)
17.14
Key Metrics
Qtr Change %
40.06% Fall from 52W High
-14.2
Dividend yield 1yr %
0
Bacil Pharma Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
37.50
Current Price
5Day EMA
37.70
10Day EMA
38.50
12Day EMA
38.80
20Day EMA
39.50
26Day EMA
39.80
50Day EMA
40.80
100Day EMA
41.20
200Day EMA
37.20
5Day SMA
37.20
10Day SMA
39.00
20Day SMA
40.60
30Day SMA
40.50
50Day SMA
40.40
100Day SMA
45.10
150Day SMA
43.30
200Day SMA
37.30
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 45701 Rs | 45701 Rs |
Week Rs | 45701 Rs | 45701 Rs |
Month Rs | null Rs | null Rs |
Resistance & Support
36.88
Pivot
Resistance
First Resistance
38.12
Second Resistance
38.75
Third Resistance
39.99
Support
First Support
36.25
Second support
35.01
Third Support
34.38
Relative Strength Index
42.33
Money Flow Index
78.48
MACD
-1.01
MACD Signal
-0.56
Average True Range
2.34
Average Directional Index
26.44
Rate of Change (21)
-10.50
Rate of Change (125)
-8.69
Bacil Pharma Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124.55 | 19.22 | 59.58 | 154 | 131.00 | -9.50% | 5.09% | 81.09% | 88.69% | 277.88% | 0.00% | 0.00 | 40.57 | 1.46 | |
75.75 | 22.65 | 62.35 | 99.64 | 77.98 | 7.07% | -5.11% | 5.02% | 4.12% | 55.38% | 0.00% | 22.15 | 40.57 | 2.10 | |
3.89 | 21.01 | 3.62 | 6.87 | 3.92 | 2.89% | -6.90% | -20.53% | -23.48% | -33.28% | 0.00% | 0.00 | 40.57 | 2.84 | |
39.50 | 21.61 | 6.08 | 45.45 | 40.30 | -7.71% | 12.15% | 151.43% | 499.39% | 875.31% | 0.00% | 246.88 | 33.12 | 38.58 | |
20.91 | 30.63 | 13.35 | 29.12 | 21.96 | -4.30% | -7.48% | -20.62% | 49.04% | 217.30% | 0.00% | 30.30 | 54.48 | 3.05 | |
Sunrest Lifescience Ltd. | 52.95 | 52.95 | - | - | - | - | - | - | - | - | - | - | - | - |
Bacil Pharma Share Price FAQs
How to buy Bacil Pharma shares?
You can easily buy Bacil Pharma shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Bacil Pharma ?
The 52-week high and low of Bacil Pharma share price is ₹62.56 and ₹14.85 as of 18/8/2025.
Please be aware that Bacil Pharma stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account